Low testosterone levels could lead to Alzheimer’s
By ANIWednesday, October 6, 2010
WASHINGTON - Older men with low levels of the male sex hormone, testosterone, are more prone to Alzheimer’s disease, revealed a new study.
“Having low testosterone may make you more vulnerable to Alzheimer’s disease. The take-home message is we should pay more attention to low testosterone, particularly in people who have memory problems or other signs of cognitive impairment,” said Dr. John E. Morley, director of the division of geriatric medicine at Saint Louis University and a study co-investigator.
Led by Dr. Leung-Wing Chu, who is chief of the division of geriatric medicine at Queen Mary Hospital at the University of Hong Kong, researchers studied 153 Chinese men who were recruited from social centers.
They were at least 55 years and older, lived in the community and didn’t have dementia.
Of those men, 47 had mild cognitive impairment - or problems with clear thinking and memory loss.
Within a year, 10 men who all were part of the cognitively impaired group developed probable Alzheimer’s disease.
These men also had low testosterone in their body tissues; elevated levels of the ApoE 4 (apolipoprotein E) protein, which is correlated with a higher risk of Alzheimer’s disease; and high blood pressure.
“It’s a very exciting study because we’ve shown that a low level of testosterone is one of the risk factors for Alzheimer’s disease,” said Morley.
The findings corroborate findings in previous studies of older Caucasian men that show low testosterone is associated with impaired thinking and Alzheimer’s disease.
They suggest that testosterone may have a protective value against Alzheimer’s disease.
The next step, Morley said, is to conduct a large-scale study that investigates the use of testosterone in preventing Alzheimer’s disease.
The researchers encourage studying the effectiveness of testosterone replacement in older men who have both mild memory problems and low testosterone in staving off Alzheimer’s disease.
The study was published in the Journal of Alzheimer’s Disease. (ANI)
